Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YX3D
|
|||
| Drug Name |
Olipudase alfa
|
|||
| Indication | Gaucher disease [ICD-11: 5C56.0Y; ICD-9: 272.7] | Approved | [1] | |
| Sphingolipidosis [ICD-11: 5C56.0] | Phase 2 | [2] | ||
| Company |
Sanofi/Genzyme
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Pyruvate kinase PKLR (PKLR) | Target Info | Activator | [3] |
| Sphingomyelin phosphodiesterase (SMPD1) | Target Info | Replacement | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761261. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761261 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.